M, K., Y, O., K, N., J, I., & K, K. (2025). Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age. Cureus, 17(11), e97689. https://doi.org/10.7759/cureus.97689
Chicago Style (17th ed.) CitationM, Kimura, Otoyama Y, Nishikawa K, Imamura J, and Kimura K. "Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age." Cureus 17, no. 11 (2025): e97689. https://doi.org/10.7759/cureus.97689.
MLA (9th ed.) CitationM, Kimura, et al. "Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age." Cureus, vol. 17, no. 11, 2025, p. e97689, https://doi.org/10.7759/cureus.97689.